tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Matthew Sykes, 84 are a HOLD (33.07%), 136 are a BUY (53.54%), 34 are a SELL (13.39%).
Analyst Matthew Sykes, carries an average stock price target met ratio of 66.67% that have a potential upside of 21.94% achieved within 216 days. Previously, Matthew Sykes worked at GOLDMAN SACHS, WILLIAM BLAIR.
Matthew Sykes’s has documented 492 price targets and ratings displayed on 41 stocks. The coverage was on Healthcare, Basic Materials, Industrials sectors.
Most recent stock forecast was given on TWST, Twist Bioscience Corp at 14-Nov-2025.
Analyst best performing recommendations are on ZY (ZYMERGEN).
The best stock recommendation documented was for ZY (ZYMERGEN) at 8/4/2021. The price target of $12 was fulfilled within 1 day with a profit of $3.75 (45.45%) receiving and performance score of 454.55.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 07-Apr-2021
$254
$23.75 (10.31%)
$245
22 days ago
(22-Oct-2026)
9/25 (36%)
$24.25 (10.55%)
186
Buy Since 27-Jul-2020
$270
$39.75 (17.26%)
$236
22 days ago
(22-Oct-2026)
9/26 (34.62%)
$40.25 (17.52%)
242
Buy Since 23-Apr-2025
$260
$29.75 (12.92%)
$220
22 days ago
(22-Oct-2026)
10/16 (62.5%)
$30.25 (13.17%)
118
Buy Since 20-Apr-2020
$270
$39.75 (17.26%)
$230
22 days ago
(22-Oct-2026)
12/20 (60%)
$40.25 (17.52%)
122
Buy Since 22-Apr-2025
$260
$29.75 (12.92%)
$255
22 days ago
(22-Oct-2026)
20/30 (66.67%)
$30.25 (13.17%)
214
